About the Panelists

Tom Bradstreet is Director, Preclinical Biomarkers & Discovery Biostatistics at Bristol-Myers Squibb (8 years). He emphasizes design-to-decision making statistical strategies while closely collaborating with, mentoring, and empowering preclinical scientists; primarily biologists and imaging experts. Tom’s current statistical interests are Bayesian statistics and statistical education. Previously, Tom was employed at Merck (32 years) contributing to Animal Safety Assessment, Experimental Medicine, Clinical Pharmacology, Modeling and Simulation, and Phase III clinical trials. He earned his undergraduate degree in Biology, Masters degrees in Biostatistics and Statistics, and his Ph.D. in Statistics.

Nareen Katta works as a Sr. Director and Head of Clinical Analytics at AbbVie. Nareen has over 20 years of experience in the pharmaceutical industry. In his current role, Nareen is responsible for building and executing the data science and advanced analytics strategy, that covers both Scientific and Business Operations, across Clinical Development, Precision Medicine and R&D. In addition to Clinical Analytics, Nareen is actively engaged in evaluating the opportunities created by the recent technology trends like big data, automation, AI, digital health etc. and strategically instantiating them at AbbVie to drive organizational transformation.

Qiqi Deng is a Director in Clinical Biostatistics at Moderna. She leads a group focusing on clinical development of public health and latent virus vaccines, as well as statistical research. Before joining Moderna, she worked in Boehringer Ingelheim for thirteen years, with seven years serving as leading statistician for multiple projects, across different clinical development phases and therapeutic areas. After that, she worked as a methodology statistician for six years, with focus on statistical methodology innovation globally. Her main research area includes hypothesis testing and modeling in dose finding, adaptive design, and pragmatic considerations in applying innovative methodology into real clinical studies. She publishes on wide array of statistical topics in her main area and beyond, e.g. multiplicity adjustment, Bayesian statistics. Dr. Deng received her bachelor’s degree in Mathematics from Peking University in China, and obtained her Ph. D. in Statistics from University of Minnesota.

About the Moderator

Hannah Waddel is a biostatistics PhD candidate at Emory University, in her fourth year. Her dissertation research focuses on infectious disease modeling, particularly for swine influenza. She has also conducted collaborative research in meta-analyses, nutrition, and cerebrovascular diseases. Hannah serves on the executive committee for the NISS Graduate Student Network. She received a BS in Mathematics from the University of Utah and an MS in Biostatistics from Emory University.